Exact Mass: 431.2519
Exact Mass Matches: 431.2519
Found 198 metabolites which its exact mass value is equals to given mass value 431.2519
,
within given mass tolerance error 0.01 dalton. Try search metabolite list with more accurate mass tolerance error
0.001 dalton.
N-Docosahexaenoyl Cysteine
N-docosahexaenoyl cysteine belongs to the class of compounds known as N-acylamides. These are molecules characterized by a fatty acyl group linked to a primary amine by an amide bond. More specifically, it is a Docosahexaenoyl amide of Cysteine. It is believed that there are more than 800 types of N-acylamides in the human body. N-acylamides fall into several categories: amino acid conjugates (e.g., those acyl amides conjugated with amino acids), neurotransmitter conjugates (e.g., those acylamides conjugated with neurotransmitters), ethanolamine conjugates (e.g., those acylamides conjugated to ethanolamine), and taurine conjugates (e.g., those acyamides conjugated to taurine). N-Docosahexaenoyl Cysteine is an amino acid conjugate. N-acylamides can be classified into 9 different categories depending on the size of their acyl-group: 1) short-chain N-acylamides; 2) medium-chain N-acylamides; 3) long-chain N-acylamides; and 4) very long-chain N-acylamides; 5) hydroxy N-acylamides; 6) branched chain N-acylamides; 7) unsaturated N-acylamides; 8) dicarboxylic N-acylamides and 9) miscellaneous N-acylamides. N-Docosahexaenoyl Cysteine is therefore classified as a very long chain N-acylamide. N-acyl amides have a variety of signaling functions in physiology, including in cardiovascular activity, metabolic homeostasis, memory, cognition, pain, motor control and others (PMID: 15655504). N-acyl amides have also been shown to play a role in cell migration, inflammation and certain pathological conditions such as diabetes, cancer, neurodegenerative disease, and obesity (PMID: 23144998; PMID: 25136293; PMID: 28854168).N-acyl amides can be synthesized both endogenously and by gut microbiota (PMID: 28854168). N-acylamides can be biosynthesized via different routes, depending on the parent amine group. N-acyl ethanolamines (NAEs) are formed via the hydrolysis of an unusual phospholipid precursor, N-acyl-phosphatidylethanolamine (NAPE), by a specific phospholipase D. N-acyl amino acids are synthesized via a circulating peptidase M20 domain containing 1 (PM20D1), which can catalyze the bidirectional the condensation and hydrolysis of a variety of N-acyl amino acids. The degradation of N-acylamides is largely mediated by an enzyme called fatty acid amide hydrolase (FAAH), which catalyzes the hydrolysis of N-acylamides into fatty acids and the biogenic amines. Many N-acylamides are involved in lipid signaling system through interactions with transient receptor potential channels (TRP). TRP channel proteins interact with N-acyl amides such as N-arachidonoyl ethanolamide (Anandamide), N-arachidonoyl dopamine and others in an opportunistic fashion (PMID: 23178153). This signaling system has been shown to play a role in the physiological processes involved in inflammation (PMID: 25136293). Other N-acyl amides, including N-oleoyl-glutamine, have also been characterized as TRP channel antagonists (PMID: 29967167). N-acylamides have also been shown to have G-protein-coupled receptors (GPCRs) binding activity (PMID: 28854168). The study of N-acylamides is an active area of research and it is likely that many novel N-acylamides will be discovered in the coming years. It is also likely that many novel roles in health and disease will be uncovered for these molecules.
Ala Arg Ser Val
Ala Arg Val Ser
Ala Ser Arg Val
Ala Ser Val Arg
Ala Val Arg Ser
Ala Val Ser Arg
Gly Ile Arg Ser
Gly Ile Ser Arg
Gly Leu Arg Ser
Gly Leu Ser Arg
Gly Arg Ile Ser
Gly Arg Leu Ser
Gly Arg Ser Ile
Gly Arg Ser Leu
Gly Arg Thr Val
Gly Arg Val Thr
Gly Ser Ile Arg
Gly Ser Leu Arg
Gly Ser Arg Ile
Gly Ser Arg Leu
Gly Thr Arg Val
Gly Thr Val Arg
Gly Val Arg Thr
Gly Val Thr Arg
Ile Gly Arg Ser
Ile Gly Ser Arg
Ile Arg Gly Ser
Ile Arg Ser Gly
Ile Ser Gly Arg
Ile Ser Arg Gly
Leu Gly Arg Ser
Leu Gly Ser Arg
Leu Arg Gly Ser
Leu Arg Ser Gly
Leu Ser Gly Arg
Leu Ser Arg Gly
Arg Ala Ser Val
Arg Ala Val Ser
Arg Gly Ile Ser
Arg Gly Leu Ser
Arg Gly Ser Ile
Arg Gly Ser Leu
Arg Gly Thr Val
Arg Gly Val Thr
Arg Ile Gly Ser
Arg Ile Ser Gly
Arg Leu Gly Ser
Arg Leu Ser Gly
Arg Ser Ala Val
Arg Ser Gly Ile
Arg Ser Gly Leu
Arg Ser Ile Gly
Arg Ser Leu Gly
Arg Ser Val Ala
Arg Thr Gly Val
Arg Thr Val Gly
Arg Val Ala Ser
Arg Val Gly Thr
Arg Val Ser Ala
Arg Val Thr Gly
Ser Ala Arg Val
Ser Ala Val Arg
Ser Gly Ile Arg
Ser Gly Leu Arg
Ser Gly Arg Ile
Ser Gly Arg Leu
Ser Ile Gly Arg
Ser Ile Arg Gly
Ser Leu Gly Arg
Ser Leu Arg Gly
Ser Arg Ala Val
Ser Arg Gly Ile
Ser Arg Gly Leu
Ser Arg Ile Gly
Ser Arg Leu Gly
Ser Arg Val Ala
Ser Val Ala Arg
Ser Val Arg Ala
Thr Gly Arg Val
Thr Gly Val Arg
Thr Arg Gly Val
Thr Arg Val Gly
Thr Val Gly Arg
Thr Val Arg Gly
Val Ala Arg Ser
Val Ala Ser Arg
Val Gly Arg Thr
Val Gly Thr Arg
Val Arg Ala Ser
Val Arg Gly Thr
Val Arg Ser Ala
Val Arg Thr Gly
Val Ser Ala Arg
Val Ser Arg Ala
Val Thr Gly Arg
Val Thr Arg Gly
[4-[bis[4-(dimethylamino)phenyl]methylene]-2,5-cyclohexadien-1-ylidene]dimethylammonium acetate
(R)-2-((9-ISOPROPYL-6-((3-(PYRIDIN-2-YL)BENZYL)AMINO)-9H-PURIN-2-YL)AMINO)BUTAN-1-OL
6-AMINO-5-(2,2-DIETHOXYETHYL)-2-((4-(2-(PYRROLIDIN-1-YL)ETHOXY)PHENYL)AMINO)PYRIMIDIN-4(3H)-ONE
2-[2-[4-[(2-cyanoethyl)ethylamino]-o-tolyl]vinyl]-1,3,3-trimethyl-3H-indolium acetate
8-Cyclopentyl-5-methyl-2-{[5-(1-piperazinyl)-2-pyridinyl]amino}-6-vinylpyrido[2,3-d]pyrimidin-7(8H)-one
1-Butyl-5-[2-(1-butyl-3,3-dimethyl-1,3-dihydroindol-2-ylidene)ethylidene]-4-methyl-2,6-dioxo-1,2,5,6-tetrahydropyridine-3-carbonitrile
(2R)-2-({9-(1-methylethyl)-6-[(4-pyridin-2-ylbenzyl)amino]-9H-purin-2-yl}amino)butan-1-ol
(2S)-2-[[9-propan-2-yl-6-[[4-(2-pyridinyl)phenyl]methylamino]-2-purinyl]amino]-1-butanol
Splenotritin
D006730 - Hormones, Hormone Substitutes, and Hormone Antagonists > D006728 - Hormones